Patient data characteristics | n | ||
---|---|---|---|
 | Group | ||
 | Small-T | Large-T | |
Total number of patients | 96 | 68 | 28 |
Sex (%) | |||
 Female | 17.7%(17) | 12 | 5 |
 Male | 82.3%(79) | 56 | 23 |
Tumor staging | |||
 III | 47 | 47 | 0 |
 IV | 49 | 21 | 28 |
 Concurrent chemoradiotherapy | 45 | 34 | 11 |
 Radiotherapy | 51 | 34 | 17 |
Disease state (RECIST1.1) | |||
 Complete remission | 7.3%(7) | 6 | 1 |
 Partial remission | 70.8%(68) | 50 | 18 |
 Stable disease | 6.3%(6) | 3 | 3 |
 Disease progression | 15.6%(15) | 9 | 6 |
Threshold volume of primary tumor (cm3) | 32.45 | Â | Â |
Threshold volume of metastatic lymph node (cm3) | 6.05 | Â | Â |
T-grouping situation | |||
 | 96 | 68 | 28 |
Volume range of primary tumo r(cm3) [min,max] | [2.1,174.4] | Â | Â |
N-grouping situation | |||
 | 73 | 32 | 41 |
 Volume range of lymph node (cm3) [min,max] | [0.5,97.9] |  |  |
 OS (month) (median, [IQR]) | 26 [19,41] |  |  |
VSR (%) (median, [IQR]) | |||
 VSR-T | 56.47 [33.09,77.61] |  |  |
 VSR-N | 89.56[65.87,100] |  |  |